Table 3.

Perceived Benefits of CCOP Participation

	Organizational Perspectives	Physician Perspectives
Internal Organizational Benefits	“[I]t has helped us in the recruitment of physicians… The new doctors coming out of school want to go to a place that offers clinical trials and that they can participate in research.” “to bring in better physicians, to engage physicians at a higher level” “I know there are patients that know [this organization] because of the CCOP.” “You know, we retain patients here. They kind of walk them through every step of the way throughout their care.”	“Attracting and retaining high-quality physicians. …I think having the CCOP has made that easy.” “And the unexpected benefit as far as getting better doctors will also get you more patients.” “So we benefit by having that additional business that you know drives and feeds everybody’s work around here. So you come here with an oncology problem and you end up having a neurologic problem. … so everybody benefits.”
External Organizational Benefits	“And I think it also enhanced our reputation among patients and residents of [this area] and around to know that they can rely on us and they don’t have to go [to other places].” “it elevates the community’s impression of the institution.” “it has definitely helped us bring in pharmaceutical contracts and things like that.” “I think it’s also increased our reputation as being an organization that is committed to research, that is committed to being cutting-edge.” “I certainly think other funders would view that as a positive if they were making a decision about placing their funds within a particular organization to know that an organization had achieved the status of being a CCOP.”	“There is, you know, prestige, and the fact that your practice is very well-respected and having the ability to claim that you are a part of the National Cancer Research Institute network has a lot of value.” “I think that the CCOP would probably make us more attractive because it sort of lends an air of organization. … otherwise you wouldn’t have been awarded the CCOP grant.” “we are large enough as a CCOP that now that NCI, you know, they almost can’t do some of the big studies without engaging us.” “You know, if you develop a reputation as somebody that is a guardian of the data and you take that seriously, that reputation’s going to carry over to those trials. And I think pharmaceutical companies are smart enough to know there are certain places they’re going to stay away from and there are certain places they’re going try to go to to open trials up.”
Quality of Care Benefits	“Whether it’s new guidelines, new clinical pathways, new options for treatment. Things like that to keep it in the forefront and push things that it’s designed to push our outcomes to a higher level.” “The quality of care is higher because of their involvement within research.” “Those are things that are standard now, but they were done earlier here because we were participating in trials.” “It’s allowed us to be able to offer to our patients a much broader spectrum of treatment options.”	“I think when you are actively involved in research protocols it really keeps you actively involved in what is going on and changes and the trends.” “So I guess that makes me feel current…and it makes me feel that I’m contributing to an effort so I won’t have to tell the patients the same old tired stuff that I’ve been telling them for the last 25 years.” “And what it’s helped me do is to give patients cutting-edge treatments that wouldn’t be available otherwise.” “Getting new drugs to patients, changing the way that we practice oncology. Those are the two major benefits.”